CRISPR-Cas9 and the Theo-Ethics of Gene Editing
A panel-guided ethical and theological dialogue
The purpose of this event is to assist participants in thinking theologically and ethically about how gene-editing technology (esp. CRISPR) is challenging our understanding of what it means to be human, and how humans act as stewards of God’s creation. In the past 10 years, CRISPR technology has made a reality of human gene editing as well as creating novel genetically modified plants and animals. Applications include human health, human enhancement, food source enhancement, pest elimination, and the creation of innovative biological weapons. Using both an ethical and theological lens, our panel will guide our conversation on the potential risks and benefits of this new technology.
Panel participants include:
Dr. Francoise Baylis, University Research Professor, NTE Impact Ethics, Faculty of Medicine, Dalhousie University
Dr. Moira McQueen, Executive Director, Canadian Catholic Bioethics Institute
Rev. Dr. Tracy Trothen, Professor of Ethics, Queen’s University
Michael Buttrey, doctoral candidate in Christian Ethics, Regis College
For more information, please contact Rev. Dr. Peter Kuhnert (email@example.com).
Organized by the Faith and Life Sciences Reference Group of The Canadian Council of Churches